IHS Chemical Week

Archives :: Markets :: Fine Chemicals/Biotech

Displaying 241 - 260 of 2083 stories.
January 28, 2014
Albemarle today reported fourth-quarter adjusted earnings of $88.4 million, or $1.08/share, down 16% year-on-year (YOY), but ahead of analysts' consensus estimate of $1.04/share as...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Albemarle-earnings-fall-YOY-but-beat-estimates_58379.html
January 28, 2014
Informex 2014: Rising certainty despite challenges for pharma Attendees and exhibitors at this year's Informex USA, held last week in Miami Beach, were mostly optimistic about the...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Pharmafine-chemicals-roundup-28-January-2014_58352.html
January 27, 2014
Makhteshim Agan Industries (MAI), the world’s leading supplier of generic crop protection chemicals, has announced that it will transition to a new global brand, Adama, beginning...
http://www.chemweek.com/markets/fine_chemicals_biotech/agricultural_chemicals/Makhteshim-Agan-changes-name-to-Adama-Agricultural-Solutions_58323.html
January 24, 2014
The US Food and Drug Administration (FDA) announced on 23 January that it has notified Ranbaxy Laboratories (Gurgaon, India), that it is prohibited from manufacturing and distributing...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/FDA-prohibits-Ranbaxy-API-plant-from-producing-and-distributing-products-for-US-market_58291.html
January 23, 2014
Attendees and exhibitors at this year's Informex USA, held this week in Miami Beach, were mostly optimistic about the direction of the fine chemicals and contract manufacturing...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Informex-2014-Rising-certainty-despite-challenges-for-pharma_58279.html
January 23, 2014
BioAmber (Minneapolis) today announced it has signed a take-or-pay contract for biobased 1,4-butanediol (BDO) with global chemical trader Vinmar International. Under the terms of the...
http://www.chemweek.com/markets/fine_chemicals_biotech/industrial_biotech/Vinmar-signs-BDO-offtake-agreement-with-BioAmber_58200.html
January 23, 2014
Biodiesel producer Renewable Energy Group (Ames, IA) today announced it has acquired renewable chemical technology developer LS9 for a purchase price of up to $61.5 million, consisting...
http://www.chemweek.com/markets/fine_chemicals_biotech/industrial_biotech/Biodiesel-firm-acquires-LS9-for-$61-million_58203.html
January 23, 2014
Lonza recorded a 44.2% fall in profits for 2013 compared with 2012, to 87 million Swiss francs ($95.7 million). Sales for 2013 decreased by 4.2%, to SF3.58 billion, due to lower sales...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Lonza-reports-fall-in-profits-sales_58208.html
January 22, 2014
Reform of the Toxic Substances Control Act (TSCA), along with trade-related issues, are the top regulatory concerns at Informex this year, attendees and exhibitors say. Socma's number...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Informex-2014-TSCA-trade-top-Socmas-regulatory-agenda_58196.html
January 22, 2014
Yulex Corporation (Phoenix) an agricultural biomaterials company, today announced the opening of a seed and genetics center focused on plant breeding, molecular genetics, and...
http://www.chemweek.com/markets/fine_chemicals_biotech/seeds_and_traits/Yulex-opens-center-for-guayule-research_58165.html
January 21, 2014
The Excipact Association, a project of the IPEC Federation (Brussels), says that Sepiprod (Castres, France) has received an Excipact certification from mdc medical device...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Air-Liquide-unit-gets-Excipact-certification-as-pharmaceutical-excipient-supplier_58140.html
January 21, 2014
Feature Antibody-drug conjugates: A developing market with substantial growth potential The antibody-drug conjugates (ADCs) market, which is in its early stages of development, offers...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Pharmafine-chemicals-roundup-21-January-2014_58141.html
January 20, 2014
Aurobindo Pharma (Hyderabad, India) says it will acquire the commercial operations of Actavis (Dublin) in seven Western European countries. Aurobindo will acquire Actavis'...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Actavis-to-sell-operations-in-seven-European-countries-to-Aurobindo_58122.html
January 17, 2014
FMC says it initiated litigation on 16 January against Summit Agro Ukraine (Kiev) and Summit North American Holdings Corp. (Wilmington, DE) in the United States District Court at...
http://www.chemweek.com/markets/fine_chemicals_biotech/agricultural_chemicals/FMC-files-patent-infringement-lawsuit-against-Summit-Agro_58047.html
January 14, 2014
H.I.G. reaches deal to acquire parent of Ampac Fine Chemicals for $392 million American Pacific (Ampac; Las Vegas), the parent company of Ampac Fine Chemicals (AFC; Rancho Cordova...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Pharmafine-chemicals-roundup-14-January-2014_57942.html
January 13, 2014
Tekmira Pharmaceuticals, a leading developer of RNA interference (RNAi) therapeutics, announced today that it has signed an option agreement under which Monsanto may obtain a license...
http://www.chemweek.com/markets/fine_chemicals_biotech/agricultural_chemicals/Monsanto-signs-option-agreement-to-support-biologicals-platform_57923.html
January 13, 2014
Ranbaxy Laboratories (Gurgaon, India), India’s largest drugs maker and member of the Daiichi Sankyo Group (Tokyo), has been notified by the US Food and Drug Administration (FDA)...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Ranbaxy-receives-FDA-notice-of-possible-API-plant-violations_57920.html
January 10, 2014
Solazyme (South San Francisco) announced today that Jean-Marc Rotsaert has resigned as COO and that, given the recent appointment of David Cole as president, the company does not plan...
http://www.chemweek.com/markets/fine_chemicals_biotech/industrial_biotech/Solazyme-shuffles-management_57900.html
January 9, 2014
Biochemical firm Myriant (Quincy, MA) has withdrawn its plans for a $125-million initial public offering, according to an SEC filing dated 8 January. The move comes shortly after PTT...
http://www.chemweek.com/markets/fine_chemicals_biotech/industrial_biotech/Myriant-withdraws-IPO_57845.html
January 9, 2014
Erez Vigodman. Teva Pharmaceutical Industries (PetaŠł• Tiqwa, Israel) says that Erez Vigodman, 54, has been appointed as president and CEO, effective 1 February. Teva announced on 30...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Teva-names-Makhteshim-Agan-boss-as-new-CEO_57824.html
Pages: « Previous  4 5 6 7 8 9 10 11 12 [13] 14 15 16 17 18 19 20 21 22 Next »










 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2014 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa